Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial

Title:	Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial
Authors:	Rampal, Raajit K.^Aff1; Grosicki, Sebastian^Aff2; Chraniuk, Dominik^Aff3; Abruzzese, Elisabetta^Aff4; Bose, Prithviraj^Aff5; Gerds, Aaron T.^Aff6; Vannucchi, Alessandro M.^Aff7; Palandri, Francesca^Aff8; Lee, Sung-Eun^Aff9; Gupta, Vikas^Aff10; Lucchesi, Alessandro^Aff11; Oh, Stephen T.^Aff12; Kuykendall, Andrew T.^Aff13; Patriarca, Andrea^Aff14; Álvarez-Larrán, Alberto^Aff15; Mesa, Ruben^Aff16; Kiladjian, Jean-Jacques^Aff17; Talpaz, Moshe^Aff18; Scandura, Joseph M.^Aff19; Lavie, David^Aff20; Harris, Morgan^Aff21; Kays, Sarah-Katharina^Aff22; Li, Qing^Aff23; Boxhammer, Rainer^Aff22; Brown, Barbara^Aff21; Jegg, Anna-Maria^Aff22; Harrison, Claire N.^Aff24; Mascarenhas, John^{Aff25, IDs41591025035723_cor1}
Source:	Nature Medicine. 31(5):1531-1538
Database:	Springer Nature Journals